Pharmacokinetics of Opicapone and Its Metabolites in Healthy White and Chinese Subjects-Reference-Cited by-同舟云学术

Pharmacokinetics of Opicapone and Its Metabolites in Healthy White and Chinese Subjects

Published:2021-04-17 Issue:11 Volume:10 Page:1316-1324
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharmacology in Drug Development

Author:

Xue Wei¹,Tan Yan²,Liu Yue¹,Xu Changjiang²,Cong Duanduan¹,Zhong Liping²,Song Jie²,Hui Aimin²,Qi Wenyuan¹,Wang Juan¹,Liu Xiaohui¹,Li Kexin¹

Affiliation:

1. Clinical Trial Center, Beijing Hospital National Center of Gerontology Institute of Geriatric Medicine Assessment of Clinical Drugs Risk and Individual Application Key Laboratory Chinese Academy of Medical Sciences Beijing China

2. Clinical Research Department Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd Shanghai China

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.922

Reference26 articles.

1. Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai

2. Levodopa in the treatment of Parkinson's disease: Current controversies

3. Variable Absorption of Carbidopa Affects Both Peripheral and Central Levodopa Metabolism

4. Comparison of the pharmacokinetics of an oral extended‐release capsule formulation of carbidopa‐levodopa (IPX066) with immediate‐release carbidopa‐levodopa (Sinemet), sustained‐release carbidopa‐levodopa (Sinemet CR), and carbidopa‐levodopa‐entacapone (Stalevo);Ann H;J Clin Pharmacol,2015

5. Catechol-O-methyltransferase and Its Inhibitors in Parkinson's Disease

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics, Pharmacodynamics, and Tolerability of Opicapone in Healthy Chinese and Caucasian Subjects: An Open-Label, Single-Center, Phase 1 Study;Neurology and Therapy;2022-01-10